Oncology

When it’s too risky to go for blood tests, the blood tests must come to the patient

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

Minimal residual disease testing by immunosequencing can yield vital information about patients’ disease and management

In a newly identified form of Richter’s transformation, an indolent B-cell lymphoma may develop into aggressive T-cell disease

In-house testing offers labs the ability to research, educate, and achieve complete coordination with clinical colleagues

To improve cancer screening compliance, patients may benefit from sensitive, specific, noninvasive blood tests

A new combination of urine biomarkers could help avoid the 60 percent of unnecessary biopsies for prostate cancer

A comparison of commonly used NGS assays for the detection of fusion genes based on a recent educational webinar

In an interview with Pallavi A. Patil, Christopher D.M. Fletcher discusses what he has learned over a 35-year-long career in pathology

A new microfluidic chip analyzes urine samples to detect prostate cancer cells.